Emergent BioSolutions Inc.
EBSNYSEHealthcare● Active
$8.03
$-0.04(-0.50%)
Market Cap$414318289
P/E Ratio—
52W High$14.06
52W Low$5.62
Emergent BioSolutions Inc.（EBS）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EBS · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.74B | $1.04B | $1.05B | $1.12B | $1.77B |
| Cost of Revenue | $0.39B | $0.67B | $0.69B | $0.64B | $0.98B |
| Gross Profit | $0.35B | $0.38B | $0.36B | $0.47B | $0.79B |
| Gross Margin %(computed) | 47.19% | 35.97% | 34.31% | 42.33% | 44.72% |
| Operating Expenses | |||||
| R&D Expenses | $0.05B | $0.07B | $0.11B | $0.19B | $0.24B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.24B | $0.48B | $1.09B | $0.64B | $0.45B |
| Operating Income | $0.11B | ($0.11B) | ($0.73B) | ($0.17B) | $0.34B |
| Operating Margin %(computed) | 14.83% | -10.42% | -69.23% | -15.21% | 19.25% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.06B | $0.07B | $0.09B | $0.04B | $0.03B |
| Income Before Tax | $0.08B | ($0.14B) | ($0.73B) | ($0.22B) | $0.30B |
| Income Tax Expense | $0.03B | $0.05B | $0.03B | ($0.01B) | $0.08B |
| Net Income | $0.05B | ($0.19B) | ($0.76B) | ($0.21B) | $0.22B |
| Net Margin %(computed) | 7.08% | -18.26% | -72.48% | -18.94% | 12.38% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.98 | $-3.60 | $-14.85 | $-4.22 | $4.10 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| EBITDA | $0.21B | $0.05B | ($0.05B) | $0.02B | $0.50B |
| EBITDA Margin %(computed) | 28.07% | 5.12% | -4.48% | 1.40% | 28.43% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Emergent BioSolutions Inc.
关于Emergent BioSolutions Inc.（EBS）损益表
Emergent BioSolutions Inc.（EBS）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，EBS实现营收$0.74B，毛利润$0.35B（毛利率47.19%），净利润$0.05B（净利率7.08%）。
常见问题
EBS · 4 问Emergent BioSolutions Inc.（EBS）2025财年营收为$0.74B，同比down28.8%。
EBS revenueEBS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08